Form D · Biotechnology
Good Start Genetics, Inc.
Cambridge, MA · CIK 0001497300
Offering snapshot reported Apr 2, 2012 · SEC filing
- Reported sold
- $10M Offering amount: $14M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 16, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 2, 2012 | Initial | $10,000,002 | No comparison | 5 | SEC filing |
| Sep 16, 2010 | Initial | $18,158,332 | No comparison | 7 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-176051
Source: Form D, filed Apr 2, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Marc Beer | Director |
| Eric Boutin | Director, Executive |
| Robert Carpenter | Director |
| Lutz Giebel | Director |
| Carl Gordon | Director |
| Don Hardison | Director, Executive |
| Gary Kurtzman | Director |
| Uri Laserson | Director |
| Paris Wallace | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
237 Putnam Avenue
Cambridge, MA, 02139
Cambridge, MA, 02139